Furthermore, VIP antagonist increased activated CD8+ T cell in tumor-bearing mice engrafted with pancreatic cancer cell lines23 However, the effect of VIP antagonist on macrophage polarization and function in tumor models remains unknown. Here, VIP is linked to pancreatic neoplasm.